Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome

Elmir Omerovic,Stefan James,David Erlinge,Henrik Hagström,Dimitrios Venetsanos,Loghman Henareh,Christina Ekenbäck,Joakim Alfredsson, Kristina Hambreus,Björn Redfors

American Heart Journal（2023）

引用 8|浏览6

暂无评分

摘要

The trial has been approved by the Swedish Medicinal Product Agency and the Swedish Ethical Board and is registered at ClinicalTrials.gov (NCT04666454).

查看译文

关键词

ESC,LV,NOAC,TS,WMSI

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要